Sign inJoin waitlistJoin the waitlist

Paul Volberding

Professor Emeritus · University of California (San Francisco) School of Medicine

Credentials: · ·

History

University of California (San Francisco) School of Medicine
Present

University of California-San Francisco
1979–1981
Internal Medicine
University of Utah School of Medicine
1975–1978
Univ of Minnesota, Duluth Sch of Med
1971–1975

Research

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
New England Journal of Medicine · 1987 · 2,322 citations
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial
New England Journal of Medicine · 1987 · 1,557 citations
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical…
New England Journal of Medicine · 1990 · First of over 10 authors · 1,272 citations

Donald Abrams
32 papers · 10 as a fellow
Lawrence Kaplan
20 papers · 6 as a fellow
Michael Saag
20 papers
Margaret Fischl
19 papers
DR
Douglas Richman
18 papers
Robert Schooley
17 papers
MH
Martin Hirsch
15 papers
MT
Melanie Thompson
14 papers
MC
Marcus Conant
13 papers
JK
James Kahn
12 papers
Joseph Eron
11 papers
SH
Scott Hammer
11 papers

Grants

UCSF-Bay Area Center for AIDS Research
National Institute of Allergy and Infectious Diseases · P30
Contact PI · $72.2M · University of California, San Francisco
1988–2022
Recent Advances in HIV Research
National Institute of Allergy and Infectious Diseases · R13
Contact PI · $113.9K · University of California, San Francisco
2012–2022
Ucsf-Givi Center for Aids Research
National Institute of Mental Health · P30
Contact PI · $7.4M · University of California, San Francisco
1988–2003
Cancer Center Support Grant
National Cancer Institute · P30
Project lead · University of California, San Francisco
1999–2002

Clinical trials

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2000–2006
A Study to Compare Two Anti-HIV Drug Combinations
Study chair · Completed · Phase 3
Hoffmann-La Roche
1999
Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
1999–2006